Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-820132 in Subjects With Type 2 Diabetes on Background Therapy of Metformin.
Phase of Trial: Phase I
Latest Information Update: 08 Mar 2011
At a glance
- Drugs BMS 820132 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Biomarker
- 08 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Feb 2011 Planned End Date changed from 1 Nov 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.
- 06 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.